Properties (52)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:Company
|
| gptkbp:acquisition |
gptkb:MedeAnalytics
gptkb:Gavis_Pharmaceuticals |
| gptkbp:awards |
Best Employer Brand 2021
Best Company in the Pharmaceutical Sector 2021 Pharma_Company_of_the_Year_2020 Best_Corporate_Social_Responsibility_2020 |
| gptkbp:clinicalTrials |
conducts numerous clinical trials globally
|
| gptkbp:community_engagement |
awareness campaigns
support for local education local health camps |
| gptkbp:employees |
over 20,000
|
| gptkbp:facilities |
gptkb:Brazil
gptkb:Japan gptkb:United_States multiple_locations_in_India |
| gptkbp:founded |
1968
|
| gptkbp:founder |
gptkb:Desh_Bandhu_Gupta
|
| gptkbp:headquarters |
gptkb:Mumbai,_India
|
| https://www.w3.org/2000/01/rdf-schema#label |
Lupin Inc.
|
| gptkbp:initiatives |
community health initiatives
education programs environmental sustainability programs healthcare_access_programs |
| gptkbp:market |
approximately $8 billion (2021)
|
| gptkbp:operates_in |
over 100 countries
|
| gptkbp:partnerships |
international health organizations
government health programs various global pharmaceutical companies NGOs for health awareness |
| gptkbp:products |
active pharmaceutical ingredients
generic pharmaceuticals branded pharmaceuticals |
| gptkbp:regulatoryCompliance |
WHO approvals
EMA_approvals FDA_approvals TGA_approvals |
| gptkbp:researchAndDevelopment |
focus on infectious diseases
focus on chronic diseases focus on cardiovascular diseases focus on diabetes |
| gptkbp:revenue |
$2.1 billion (2021)
|
| gptkbp:stockExchange |
LUPIN
|
| gptkbp:subsidiary |
gptkb:Lupin_Pharmaceuticals,_Inc.
gptkb:Lupin_Life_Sciences gptkb:Lupin_Limited Lupin Healthcare |
| gptkbp:sustainability_initiatives |
renewable energy usage
reduce carbon footprint water conservation efforts waste management initiatives |
| gptkbp:website |
www.lupin.com
|